x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

Safety Precautions for Laboratory Research With COVID-19 Specimens

The pandemic has brought biosafety to the spotlight. This blog discusses guidelines and safety precautions for handling COVID-19 specimens.

Read Now
7 min. read
Read more
 
Blog

Trial Design in the Time of COVID-19: Complex and Efficient

Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. Read more:

Read Now
4 min. read
Read more
 
Blog

Q&A – Ask Advarra Live: The Real-World Impact of COVID-19 on Research

We have addressed the most popular Q&A topics from our recent webinar on the research impact of COVID-19 in this blog post. Read more:

Read Now
6 min. read
Read more
 
Blog

How Sites Can Prepare for COVID-19 Genetically Engineered Vaccine Studies

Is your site prepared to participate in COVID-19 vaccine research? Registering an IBC ahead of time gives you an advantage. Read more:

Read Now
4 min. read
Read more
 
Blog

Protocol Feasibility to Promote Trial Efficiency

Many studies do not accrue subjects at the site level, which contributes to a significant amount of waste of staff time and monetary resources. Read more:

Read Now
8 min. read
Read more
 
Blog

Study Activation: A Complex Process That Doesn’t Have to Be Painful

If the clinical development time of a new treatment is to ever decrease, reducing the time in study activation is necessary so actual research can be done.

Read Now
3 min. read
Read more
 
Blog

How Research Informs the COVID-19 Response

Research doesn’t just inform medical treatment; it informs public health and public policy, and it helps explain human behaviors. Read more:

Read Now
5 min. read
Read more
 
Blog

IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider

Advarra IRB experts discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review. Read more:

Read Now
5 min. read
Read more
 
Blog

Key Biosafety Considerations for Coronavirus Research

Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:

Read Now
7 min. read
Read more